Hedge Fund - Darwin Global Management
Moonlake Immunotherapeutics ()
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2023 - Q4 (2023-12-31) | $62,762,663 | 12.31% | 1,039,289 | $ |
The displayed share prices are average quarterly stock market prices.